Low density lipoprotein (LDL) metabolism by human skin fibroblasts was studied using LDL labeled in the neutral lipid fraction with a nonhydrolysable cholesteryl ester analogue 3 H-cholesteryl linoleyl ether ( 3 H-CLE-LDL). LDL uptake could be quantitated accurately using 3 H-CLE-LDL, since the label accumulated intracellularly due to its resistance to hydrolysis. L ow density lipoproteins (LDL) are metabolized by normal skin fibroblasts via a well-defined sequence of events commonly known as the "LDL pathway."
L ow density lipoproteins (LDL) are metabolized by normal skin fibroblasts via a well-defined sequence of events commonly known as the "LDL pathway."
1 Following receptor-mediated uptake, the LDL particles undergo hydrolysis in lysosomes and in this way serve to deliver cholesterol to the cell.
In recent years, cholesteryl linoleyl ether, a nonhydrolyzable analogue of cholesteryl linoleate, has been used to study the fate of plasma lipoprotein cholesteryl ester in vivo. 2 " 5 The labeling of the LDL with 3 H-CLE, as catalyzed by cholesteryl ester transfer protein, does not require partial delipidation or the treatment of the native lipoproteins with detergents. The labeled LDL thus appears suitable for investigations in vivo because it is cleared from the circulation with a V/2 of about 7 hours. 3 These data were obtained by injecting human 3 H-CLE-LDL into rats. The aim of the present study was to evaluate the metabolism of LDL labeled in this way in a homologous system; thus, we used human skin fibroblasts from normal and apo B,E receptor-negative cells to determine the suitability of human LDL labeled with cholesteryl linoleyl ether for studying receptor-mediated uptake of LDL.
were established from a skin biopsy obtained from the ventral surface of the forearm of a homozygous familial hypercholesterolemic patient and were confirmed as being homozygous receptor-negative (unpublished data). The cells were maintained in culture as described previously, 6 and were used between Passages 5-19. Cells were plated at 10 5 cells per 60 mm dish, and cells in late-logarithmic growth (Day 5) were used in the experiments.
Llpoprotelns
Human LDL (d = 1.019-1.063 g/ml) and lipoprotein-deficient serum (d > 1.25 g/ml) (LPDS) were isolated from pooled human blood, and the LDL was washed and labeled with 125 lodine as described previously. 7 LDL labeling with 3 H-cholesteryl linoleyl ether was performed as described. 3 The specific radioactivity obtained in the two types of labeled LDL preparations corresponded to 200-400 cpm/ng LDL protein in the case of 125 I-LDL and 1800-3400 dpm/ g LDL protein in the case of 3 H-CLE-LDL.
LDL Binding and Metabolism
After 5 days in culture, the number of LDL receptors was up-regulated (unless otherwise stated) by incubating the cells for 48 hours in Eagle's minimum essential medium containing human LPDS (5 mg protein/ml) (MEM/LPDS). 6 Each cell layer then received 2 ml of MEM/LPDS and the indicated concentration of either 125 I-LDL or 3 H-CLE-LDL. The dishes were incubated at 37°C for the indicated time periods, after which the medium was collected, and in the case of 1 2 5 I, used for the determination of protein degradation products. 8 The cell layer was washed four times with 0.2% albumin in phosphate-buffered saline (PBS) and three times with PBS at 4°C. The cells were released from the petri dish by incubation for 5 minutes at 37°C with 0.05% trypsin and 0.01% EDTA in PBS. Following inactivation of the trypsin by the addition of serum-containing medium, the cells were separated by centrifugation at 2000 rpm for 15 minutes, and the trypsin supernatant was designated trypsin-releasable material. The cell pellet was washed twice by centrifugation in PBS, and lipids were extracted with chloroform/methanol, 1:1 (vol/ vol). The lipid-extracted pellets were dissolved in 0.5 N NaOH and used for the determination of cellular 125 I uptake and protein, the latter according to Lowry et al. 9 The cellular protein ranged between 150 /u.g and 200 /j.g protein per dish. The 3 H-radioactivity of an aliquot of the trypsin supernatant and of the dried lipid extract of the cell pellets was determined in a p scintillation spectrometer (Beckman Instruments, La Jolla, California) with Instagel (Packard Instrument Company, Inc., Downers Grove, Illinois) as scintillator.
In the experiment in which cells were exposed to labeled LDL and then postincubated in nonlabeled medium at 37°C, the cell layers were washed four times with PBS containing 0.2% albumin, and three times with PBS at 4°C, before the addition of the postincubation medium that consisted of MEM/ LPDS without added lipoproteins. At the indicated times thereafter, cell layers were treated and analyzed as described above. In all experiments, data points represent means of duplicate dishes, which did not differ from each other by more than 10%.
Results
Human skin fibroblasts were incubated with LDL preparations labeled either in the lipid fraction with a nonhydrolysable cholesteryl ester analogue, 3 Hcholestryl linoleyl ether ( 3 H-CLE-LDL), or in the protein moiety with 125 I ( 125 I-LDL). Trypsin was used to remove cell surface-bound LDL, and the amount of uptake of 125 I-LDL was calculated from the sum of cellular trypsin-resistant radioactivity and the radioactivity that appeared in the medium as a result of apo B degradation. The uptake of 3 H-CLE-LDL was considered to be equivalent to the trypsin-resistant intracellular radioactivity. Uptake values were expressed as a percentage of the total labeled material present initially in the medium, as this provided a convenient means of comparing the extent of LDL metabolism using either label. In seven experiments, the extent of LDL uptake was studied using two different batches of 3 H-CLE-LDL and 125 I-LDL The mean values showed a slightly higher uptake of 3 H-CLE-LDL than of 125 I-LDL, which, however, was not statistically significant; in some experiments there was slightly more uptake of 3 H-CLE-LDL, while in others there was a greater uptake of 125 I-LDL. The mean uptake values obtained in the seven comparisons were 7.63 ± 2.8 and 6.34 ± 1.8 (mean ± SD); expressed as a percentage of medium radioactivity per 200 ug cell protein per 6 hours, for 3 H-CLE-LDL and 125 I-LDL, respectively, when cells were incubated at 37°C in the presence of 20 fig protein/ml of either labeled LDL (p > 0.05, paired Mest).
To detect possible alteration or denaturation of LDL during the procedure for the incorporation of the tracer label ( 3 H-CLE), we compared the uptake rates of 3 H-CLE-LDL with the uptake rates of 125 I-LDL, which before iodination had been taken through all the preparatory steps used for 3 H-CLE-LDL, except for omission of the tracer amount of 3 H-CLE. In this experiment, 3 H-CLE-LDL uptake was 22% lower than the uptake of the control 125 I-LDL. As shown in Figure 1 , the rates of uptake of 3 H-CLE-LDL and 1 2 5 I -LDL were similar, even though in this experiment somewhat more 3 H-CLE-LDL than 125 I-LDL was taken up at all time intervals. To confirm that the 3 Hcholesteryl linoleyl ether remained cell-associated, cells that had been exposed to 3 H-CLE-LDL or 1 2 5 I -LDL were postincubated in LPDS medium for 24 hours ( Figure 2 ). As expected, in cells labeled with 125 I-LDL, the cell-associated 125 l-labeled protein was hydrolyzed, and the degradation products were released into the medium. In contrast, in cells prelabeled with 3 H-CLE-LDL, the amount of trypsin-resistant, intracellular 3 H-radioactivity remained constant during 24 hours of postincubation.
Three lines of evidence indicated that 3 H-CLE-LDL was internalized by fibroblasts via the LDL (apo B,E) receptor. First, the amounts of 3 H-CLE-LDL internalized revealed saturation kinetics of LDL concentration similar to the uptake of 125 I-LDL ( Figure  3 ). In this experiment more 3 H-CLE-LDL than i 2 5 l -LDL was taken up, but this was not always the case (Table 1) . Competition experiments carried out using unlabeled LDL confirmed that 3 H-CLE-LDL uptake was dependent on high-affinity saturable binding sites and that these sites recognized LDL ( Table 1 ). The cellular uptake of both 125 I-LDL and 3 H-CLE-LDL (20 ixq protein/ml) was reduced almost completely (92% and 95%, respectively) in the presence of excess unlabeled LDL (300 fig protein/ml) . In addition, the data in Table 1 indicated that the rates of 125 I-LDL and 3 H-CLE-LDL uptake were reduced to a similar extent in the presence of unlabeled LDL at concentrations of either 80 i^g protein/ml (Experiment 1) or 300 /xg protein/ml (Experiment 2).
The second line of evidence was that cells upregulated for 48 hours in MEM/LPDS took up six times as much 3 H-CLE-LDL than down-regulated After extensive washing at 4°C (see Methods), the cells were exposed to MEM/LPDS in the absence of LDL at 37°C. At the indicated times, the cells were chilled to 4°C, again extensively washed and analyzed for trypsin-releasable (•) and trypsin-resistant (o) radioactivity in both cases. In the case of 12S I-LDL, the postincubation medium was also analyzed for noniodine TCA soluble radioactivity (A), as described in Methods. All results are normalized to the amount of radioactivity that was cellassociated at the beginning of the postincubation period (100%). Values in parentheses represent high affinity labeled LDL uptake at 20 ^9 protein/ml, and were calculated by subtracting the uptake values obtained in the presence of excess unlabeled LDL (300 ng protein/ml) from the values obtained when only labeled LDL was present.
cells (data not shown). Third, the LDL receptor-negative cell strains internalized negligible amounts of H-CLE-LDL when compared with normal cells (Table  2) , even after 71 hours. The uptake of 3 H-CLE-LDL was temperature-dependent, and in two experiments the uptake into cells incubated at 18°C for 6 or 24 hours averaged 19% and 22%, respectively, of the uptake at 37°C.
In essence, the data suggested that the uptake of 1 2 5 I-and 3 H-CLE-labeled LDL was similar in both normal and receptor-negative cells. A major difference was seen, however, when the amounts of trypsin-releasable 3 H-and 125 l-radioactivity were compared. While trypsin-releasable 125 l-radioactivity remained relatively constant during a 24-hour incubation period, the trypsin-releasable ^-radioactivity steadily increased with the increasing time of incubation (Figure 4) . In five separate comparisons of the trypsin-releasable 3 H-and 125 l-radioactivities after 24 hours of incubation, the 3 H to 125 I ratios were 3.4 ± 1.8 (x ± SD) (see also Table 2 ).
A number of considerations suggested that the material released by trypsin did not simply reflect the release of radioactivity due to cell damage. Analysis of the trypsin-releasable and trypsin-resistant I-LDL over the first 2 hours of incubation indicated that the trypsin-releasable material attained constant levels after about 30 minutes, although the intracellular trypsin-resistant fraction continued to increase for up to 2 hours ( Figure 5) . A second line of evidence stems from a study of the effect of chloroquine, an inhibitor of apolipoprotein degradation (Table 3) . Chloroquine treatment resulted in a 10-fold increase in the intracellular 125 I-LDL pool. However, the amount of trypsin-releasable 125 l-material was not increased; thus, the material released from the cells by trypsin did not correspond to a randomly sampled fraction of the total intracellular pool. GM3348 cells were grown, up-regulated, and analyzed as described in the Methods section. The LDL concentration used was 20 ^g protein/ml, and values are the means of duplicate dishes.
Discussion
In this report, we demonstrated that human skin fibroblasts bind and take up LDL that is labeled in the lipid moiety with 3 H-cholesteryl linoleyl ether. As might be expected, internalization occurs via LDL receptor-mediated endocytosis; because of the nonhydrolyzable nature of this cholesteryl ester analogue it accumulates intracellularly. This result concurs with the previously reported overall stability of this compound in vivo 2 " 5 and in vitro. 10 Within the limits of the present assays, no major quantitative differences were found between the total uptake of 3 H-CLE-LDL and 125 I-LDL (intracellular + degraded). The 3 H-labeled probe accurately measured LDL uptake and obviated the problem of deiodination, which may influence the assessment of LDL uptake by the rate of protein degradation, especially in cells possessing high deiodinase activity, such as hepatocytes. 11 Thus, all the cholesteryl ester delivered to the cells could be accounted for by 125 l-protein metabolism, supporting the generally held notion that LDL is taken up as an intact particle and that hydrolysis of its components occurs intracellularly. This may not be the case with HDL, since, following injection of HDL into rats, the cholesteryl ether label from HDL is cleared more rapidly from the circulation 12 and is taken up more extensively by the liver, adrenal gland, and gonad 13 than is the labeled apoprotein.
The major difference between the cellular handling of 12fe l-LDL and 3 H-CLE-LDL was the finding that, while the amount of trypsin-releasable 125 I-LDL reached a maximum within 30 minutes, trypsin-releasable 3 H-CLE continued to increase over the 24-hour experimental period. When tested after 24 hours, at least three times more 3 H than 125 I was found in this fraction when normal human skin fibroblasts were used. No significant binding or internalization of 3 H-CLE-LDL occurred in receptor-negative cells, even after 71 hours. Taken together with the fact that the ratio of trypsin-releasable 3 H to 125 I remained constant at about 3 under conditions in which receptor activity was subjected to up-and down-regulation, these findings indicate that the accumulation of 3 H-CLE in the trypsin-releasable pool is related to the expression of the apo B,E receptor.
The information accrued during the past few years has shown that, whereas LDL particles undergo degradation in lysosomes, the vast majority of LDL receptors is recycled back to the cell surface.
14 It appears that the dissociation of the ligand from its receptor occurs to a large extent in endocytotic vesicles before endosome-lysosome fusion. 15 It has also been postulated 14 that a fraction of the receptors may accompany the ligand to the lysosomal pool and then recycle via an alternate pathway. In the case of the cholesteryl ester analogue, association of the analogue and the receptor region of the membrane may occur in lysosomes after the apolipoprotein moiety has undergone hydrolysis. Since the trypsin-releasable cholesteryl ether label represented only about 10% of the total intracellular radioactivity (not shown in Figure 4 ), one could speculate that the ether label in this fraction reflects, and may be a useful marker for, that proportion of receptors that has accompanied the ligand to the lysosomal compartment and been subsequently recycled.
